Carisoprodol (Soma): a new and
cautious perspective on an old agent
by
Littrell RA, Hayes LR, Stillner V.
College of Pharmacy,
University of Kentucky Medical Center,
Lexington 40536-0084.
South Med J 1993 Jul;86(7):753-6

ABSTRACT

Carisoprodol (Soma, others) is a commonly prescribed, noncontrolled, skeletal muscle relaxant whose active metabolite is meprobamate. Patients for whom carisoprodol is prescribed are at risk for meprobamate dependence; several such cases have been reported. Toxicity and withdrawal associated with the use of meprobamate is high and has led to abandonment of this agent in clinical practice. Because carisoprodol possesses the same risks it should be avoided when possible, and it should be given schedule IV controlled substance status.

Anxiety
Meprobamate
Methaqualone
Benzodiazepines
Future anxiolytics
Meprobamate: structure
Carisoprodol (Soma): structure
Meprobamate versus lorazepam
Carisoprodol (Soma) elimination
Meprobamate (Miltown) versus felbamate (Felbamate)

Refs
and further reading

HOME
HedWeb
Nootropics
cocaine.wiki
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family